IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Delphi Management Partners VIII, L.L.C.

Q4 2019 Holdings

Filed 2020-02-07 | 5 holdings | $126.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tandem Diabetes, Inc.(TNDM)Common Stock875372203$59.6K1,000,00047.0%
Karyopharm, Inc.(KPTIEUR)Common Stock48576U106$43.4K2,263,00634.2%
Calithera Biosciences, Inc.(CALAEUR)Common Stock13089P101$13.9K2,426,70210.9%
Senseonics Holdings, Inc.(SENS1GBP)Common Stock81727U105$9.0K9,846,2947.1%
Mereo BioPharma Group PLC(MREO)ADS589492107$842256,7340.7%